Cerity Partners’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,561
Closed -$86.7K 1856
2023
Q3
$86.7K Sell
10,561
-571
-5% -$5.53K ﹤0.01% 1340
2023
Q2
$130K Buy
11,132
+475
+4% +$4.5K ﹤0.01% 1525
2023
Q1
$82.1K Buy
10,657
+117
+1% +$949 ﹤0.01% 1783
2022
Q4
$97K Sell
10,540
-793
-7% -$8.82K ﹤0.01% 1410
2022
Q3
$110K Buy
11,333
+148
+1% +$1.85K ﹤0.01% 1104
2022
Q2
$160K Buy
+11,185
New +$191K ﹤0.01% 1104
2022
Q1
Sell
-10,879
Closed -$231K 947
2021
Q4
$231K Buy
+10,879
New +$216K ﹤0.01% 881

Other funds holding BAK

Cerity Partners's BAK Position: Q4 2023 in Review

Cerity Partners sold out of Braskem (BAK) in Q4 2023, closing a stake of 10,561 shares — an estimated $86.7K sold.

Cerity Partners first reported a position in BAK in Q4 2021 and held it in 7 quarters. The position peaked at $231K in Q4 2021. 56 funds tracked by Wall St. Rank hold BAK as of Q4 2023.

  • Cerity Partners reported no remaining Braskem position as of Q4 2023 after selling out during the quarter.
  • Cerity Partners sold 10,561 Braskem shares in Q4 2023, an estimated $86.7K.
  • Cerity Partners first reported a position in Braskem in Q4 2021 and held it in 7 quarters.
  • Cerity Partners's Braskem position peaked at $231K in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Braskem as of Q4 2023.

Based on Cerity Partners's 13F filing for Q4 2023, filed 26 Jan 2024.